BioMarin Pharmaceutical
BMRN
#1967
Rank
C$14.19 B
Marketcap
C$73.46
Share price
0.28%
Change (1 day)
-14.33%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): C$0.67 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are C$3.22 Billion. a decrease over its 2024 earnings that were of C$0.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 C$0.65 B-10.94%
2024 C$0.73 B187.31%
2023 C$0.25 B26.07%
2022 C$0.20 B-298.51%
2021 -C$0.11 Billion78.04%
2020 -C$57.51 Million-55.36%
2019 -C$0.13 Billion-33.56%
2018 -C$0.2 Billion297.78%
2017 -C$48.75 Million-95.68%
2016 -C$1.13 Billion437.12%
2015 -C$0.22 Billion23.91%
2014 -C$0.17 Billion-29.25%
2013 -C$0.24 Billion49.23%
2012 -C$0.17 Billion171.11%
2011 -C$59.29 Million103.01%
2010 -C$29.21 Million-3903.54%
2009 C$0.76 M-98.31%
2008 C$45.41 M-189.7%
2007 -C$50.64 Million51.02%
2006 -C$33.53 Million-61.58%
2005 -C$87.26 Million-56.59%
2004 -C$0.21 Billion95.13%
2003 -C$0.11 Billion12.09%
2002 -C$91.89 Million73.19%
2001 -C$53.06 Million18.32%
2000 -C$44.85 Million19.65%
1999 -C$37.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
C$10.46 B 1,495.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-C$0.7 Billion-205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-C$0.15 Billion-122.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-C$37.29 Million-105.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.25 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$0.38 B-41.24%๐Ÿ‡บ๐Ÿ‡ธ USA